Pharmacodynamics and pharmacokinetics of the methyl ester of 15-deoxy-16-hydroxy-16-vinylprostaglandin E2. 1985

V K Batra, and J A Morrison, and D B Cosulich, and W Dougherty, and N Perkinson, and M Kohlbrenner, and A Barr, and A Yacobi

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011459 Prostaglandins E, Synthetic Analogs or derivatives of prostaglandins E that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGE. PGE Synthetic,Prostaglandin E Analogs,Prostaglandin E Analogues,Synthetic Prostaglandins E,Analogs, Prostaglandin E,Analogues, Prostaglandin E,Synthetic, PGE
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015232 Dinoprostone The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. PGE2,PGE2alpha,Prostaglandin E2,Prostaglandin E2alpha,PGE2 alpha,Prepidil Gel,Prostaglandin E2 alpha,Prostenon,E2 alpha, Prostaglandin,E2, Prostaglandin,E2alpha, Prostaglandin,Gel, Prepidil,alpha, PGE2,alpha, Prostaglandin E2

Related Publications

V K Batra, and J A Morrison, and D B Cosulich, and W Dougherty, and N Perkinson, and M Kohlbrenner, and A Barr, and A Yacobi
January 1985, Journal of pharmaceutical sciences,
V K Batra, and J A Morrison, and D B Cosulich, and W Dougherty, and N Perkinson, and M Kohlbrenner, and A Barr, and A Yacobi
September 1983, The Journal of pharmacology and experimental therapeutics,
V K Batra, and J A Morrison, and D B Cosulich, and W Dougherty, and N Perkinson, and M Kohlbrenner, and A Barr, and A Yacobi
December 1986, Journal of hypertension,
V K Batra, and J A Morrison, and D B Cosulich, and W Dougherty, and N Perkinson, and M Kohlbrenner, and A Barr, and A Yacobi
January 1981, Prostaglandins,
V K Batra, and J A Morrison, and D B Cosulich, and W Dougherty, and N Perkinson, and M Kohlbrenner, and A Barr, and A Yacobi
May 1984, Life sciences,
V K Batra, and J A Morrison, and D B Cosulich, and W Dougherty, and N Perkinson, and M Kohlbrenner, and A Barr, and A Yacobi
August 1998, The Journal of organic chemistry,
V K Batra, and J A Morrison, and D B Cosulich, and W Dougherty, and N Perkinson, and M Kohlbrenner, and A Barr, and A Yacobi
December 1986, Journal of hypertension,
V K Batra, and J A Morrison, and D B Cosulich, and W Dougherty, and N Perkinson, and M Kohlbrenner, and A Barr, and A Yacobi
February 1984, Prostaglandins, leukotrienes, and medicine,
V K Batra, and J A Morrison, and D B Cosulich, and W Dougherty, and N Perkinson, and M Kohlbrenner, and A Barr, and A Yacobi
August 1974, Prostaglandins,
V K Batra, and J A Morrison, and D B Cosulich, and W Dougherty, and N Perkinson, and M Kohlbrenner, and A Barr, and A Yacobi
August 1975, Prostaglandins,
Copied contents to your clipboard!